FI922964A - Cykliska imidderivat - Google Patents

Cykliska imidderivat Download PDF

Info

Publication number
FI922964A
FI922964A FI922964A FI922964A FI922964A FI 922964 A FI922964 A FI 922964A FI 922964 A FI922964 A FI 922964A FI 922964 A FI922964 A FI 922964A FI 922964 A FI922964 A FI 922964A
Authority
FI
Finland
Prior art keywords
imidderivat
cyclic
cyclic imidderivat
Prior art date
Application number
FI922964A
Other languages
English (en)
Other versions
FI922964A0 (fi
Inventor
Peter Leslie Myers
Andrew Brian Mcelroy
Michael Gregson
Peter Jonathan Brown
Howard Geoffrey Davies
David Harold Drewry
Michael Andrew Foley
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113930A external-priority patent/GB9113930D0/en
Priority claimed from GB919113844A external-priority patent/GB9113844D0/en
Priority claimed from GB929209402A external-priority patent/GB9209402D0/en
Priority claimed from GB929210343A external-priority patent/GB9210343D0/en
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of FI922964A0 publication Critical patent/FI922964A0/fi
Publication of FI922964A publication Critical patent/FI922964A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI922964A 1991-06-27 1992-06-26 Cykliska imidderivat FI922964A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919113930A GB9113930D0 (en) 1991-06-27 1991-06-27 Chemical compounds
GB919113844A GB9113844D0 (en) 1991-06-27 1991-06-27 Chemical compounds
GB929209402A GB9209402D0 (en) 1992-04-30 1992-04-30 Chemical compounds
GB929210343A GB9210343D0 (en) 1992-05-14 1992-05-14 Chemical compounds

Publications (2)

Publication Number Publication Date
FI922964A0 FI922964A0 (fi) 1992-06-26
FI922964A true FI922964A (fi) 1992-12-28

Family

ID=27450705

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922964A FI922964A (fi) 1991-06-27 1992-06-26 Cykliska imidderivat

Country Status (10)

Country Link
US (1) US5252560A (fi)
EP (1) EP0520573A1 (fi)
JP (1) JPH0625284A (fi)
KR (1) KR930000481A (fi)
AU (1) AU1864092A (fi)
CA (1) CA2072551A1 (fi)
FI (1) FI922964A (fi)
IE (1) IE922083A1 (fi)
MX (1) MX9203643A (fi)
NO (1) NO922530L (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530161A (en) * 1991-07-08 1996-06-25 British Bio-Technology Limited Hydroxamic acid based collagenase inhibitors
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
AUPM627594A0 (en) * 1994-06-16 1994-07-07 Willis, Gregory Lynn Dr Animal bedding material
WO1996033733A1 (fr) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Nouveau remede pour affections cutanees
GB9613547D0 (en) * 1996-06-27 1996-08-28 Pharmacia Spa Matrix metalloproteinase inhibitors
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
US6861441B1 (en) 1999-08-10 2005-03-01 Smithkline Beecham Corporation Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer
EP1294699B1 (en) 2000-05-12 2016-04-13 Genzyme Corporation Modulators of tnf- alpha signalling
WO2003063891A1 (en) * 2002-01-29 2003-08-07 Wyeth Compositions and methods for modulating connexin hemichannels
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
ES2315922T3 (es) * 2004-04-14 2009-04-01 Gilead Sciences, Inc. Analogos de fosfonato de compuestos inhibidores de la integrasa del vih.
AU2015210833B2 (en) 2014-02-03 2019-01-03 Vitae Pharmaceuticals, Llc Dihydropyrrolopyridine inhibitors of ROR-gamma
CN104130144A (zh) * 2014-07-30 2014-11-05 新疆农垦科学院 酞酸酯类塑化剂通用半抗原、抗原的合成方法及应用
CA2963140A1 (en) 2014-10-14 2016-04-21 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ror-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019023207A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF RORƳ
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
KR20230158005A (ko) 2021-03-18 2023-11-17 씨젠 인크. 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2025996A1 (de) * 1970-05-27 1971-12-09 Chemie Grünenthal GmbH, 5190 Stolberg Abkömmlinge von Mercaptocarbonsäuren
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
ZW23187A1 (en) * 1986-12-15 1988-06-29 Hoffmann La Roche Phosphinic acid derivatives
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
EP0401963A1 (en) * 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptides with collagenase inhibiting activity
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
WO1991005555A2 (en) * 1989-10-13 1991-05-02 The Salk Institute Biotechnology/Industrial Associates, Inc. N-acyl peptide metalloendopeptidase inhibitors and methods of using same
WO1991005763A1 (en) * 1989-10-13 1991-05-02 The Salk Institute Biotechnology/Industrial Associates, Inc. Dipeptide-analog-based metalloendopeptidase inhibitors and methods of using same
CA2045621A1 (en) * 1989-11-24 1991-05-25 Akira Okuyama Physiologically active substance be-16627
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
GB9008078D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
EP1069137A1 (en) * 1990-09-24 2001-01-17 W.R. Grace & Co.-Conn. Peptides having thrombospondin-like activity and their therapeutic use
EP0489577B1 (en) * 1990-12-03 1995-03-22 Celltech Limited Peptidyl derivatives

Also Published As

Publication number Publication date
AU1864092A (en) 1993-01-07
KR930000481A (ko) 1993-01-15
US5252560A (en) 1993-10-12
NO922530L (no) 1992-12-28
MX9203643A (es) 1995-01-31
CA2072551A1 (en) 1992-12-28
FI922964A0 (fi) 1992-06-26
IE922083A1 (en) 1992-12-30
EP0520573A1 (en) 1992-12-30
JPH0625284A (ja) 1994-02-01
NO922530D0 (no) 1992-06-26

Similar Documents

Publication Publication Date Title
FI925387A0 (fi) Soekarrangemang i centralsystem foer cellulaer mobiltelefoni
FI930855A0 (fi) Tillaempningarnas modularitet i datakommunikationscentraler
ATE137279T1 (de) Stoffauflauf
FI933855A0 (fi) Kontinuerlig blandningsmaskin uppdelad i sektioner
FI932245A (fi) Faskombinationsfoerfarande och -anordning foer anvaendning i en flerantennmottagare
FI922964A (fi) Cykliska imidderivat
FI921435A (fi) Skydd foer saenkpump i svaora foerhaollanden
ATA131391A (de) Reibring
FI922759A (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper
FI923724A (fi) Monterings- och distansanordning foer braenslestavarna i en kokvattenreaktor
FI925206A (fi) Rengoerningsprodukt i vaetskeform
FI935507A0 (fi) Foerbaettring i en lyftbommekanism
FI935566A (fi) Insertionsmutationer i mycobakterier
FI924750A (fi) Zirkoniumbaserad legering foer komponenter i kaernreaktorer
FI922180A (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning
FI934710A (fi) 4-aryl-3-(heteroarylureido)kinolinderivat
FI933892A (fi) Topiskt tvaolgelpreparat
ATA170491A (de) Mauerstein
FI920998A (fi) Skaermad hytt i modulkonstruktion
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
FI924076A0 (fi) Cykliska nitroner.
ATA9892A (de) Formstein
FI916087A (fi) Anordning i en produktionslinje foer mineralull
FI922714A (fi) Anordning i en sf6-isolerad hoegspaenningslindningskopplare
FI934733A0 (fi) Krets foer hoegspaenningsstabilering i en televisionsmottagare

Legal Events

Date Code Title Description
FD Application lapsed